Literature DB >> 29957084

Chronic abdominal pain in irritable bowel syndrome - current and future therapies.

Anna Zielińska1, Maciej Sałaga1, Marcin Włodarczyk1,2, Jakub Fichna1.   

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) is a functional gut disorder that typically manifests in early adult years. One of the two major symptoms of the disease is chronic, visceral pain. The patients report pain as the most distressing symptom with the greatest impact on quality of life, challenging both to patients and healthcare providers. Areas covered: This review focuses on the pathophysiology of abdominal pain in IBS and describes current treatment possibilities. It also covers latest findings that may lead to novel pharmacological options in IBS pain management. Expert commentary: Pain is the main contributor to severity in IBS. Seeking pain alleviation is the most common reason that IBS sufferers consult with their physicians. Not all patients report being satisfied with available treatments for pain in IBS and there is a pressing need to find new, more efficient therapies for this syndrome.

Entities:  

Keywords:  Irritable bowel syndrome; chronic pain; microbiota; pain management; pharmacotherapy; visceral pain

Mesh:

Year:  2018        PMID: 29957084     DOI: 10.1080/17512433.2018.1494571

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  3 in total

1.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

2.  Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.

Authors:  Yan Jiang; Joel Castro; Linda V Blomster; Akello J Agwa; Jessica Maddern; Gudrun Schober; Volker Herzig; Chun Yuen Chow; Fernanda C Cardoso; Paula Demétrio De Souza França; Junior Gonzales; Christina I Schroeder; Steffen Esche; Thomas Reiner; Stuart M Brierley; Glenn F King
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

3.  Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study.

Authors:  Kathleen Van Malderen; Nikita Hanning; Helen Lambrechts; Tine Haverhals; Silke Van Marcke; Hannah Ceuleers; Joris G De Man; Benedicte Y De Winter; Kevin Lamote; Heiko U De Schepper
Journal:  Front Med (Lausanne)       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.